Nuevas fronteras en hipertension arterial /

Por Bolli, P.
Publicado em 1985

Letter: New vasodilator drugs for hypertension.

Por Bolli, P, Simpson, F O
Publicado em 1974

Atenolol ν placebo in mild hypertension: Renal, metabolic and stress antipressor effects

Por Waal-Manning, Hendrika J., Bolli, P.
Publicado em 1980

Cardioselective beta-blockade and renal function.

Por Waal-Manning, H J, Bolli, P
Publicado em 1979

Vasodilatory effect of nicardipine and verapamil in the forearm of hypertensive as compared with normotensive man

Por Hulthén, U. L., Bolli, P., Bühler, F. R.
Publicado em 1985

Prazosin in normal subjects: plasma levels, blood pressure and heart rate.

Por Wood, A J, Bolli, P, Simpson, F O
Publicado em 1976

(-)-Adrenaline-induced, calcium-dependent phosphorylation of proteins in human platelets.

Por Block, L H, Jaksche, H, Erne, P, Bolli, P, Bühler, F R
Publicado em 1985

Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Bloo...

Por Burgess, E, Lewanczuk, R, Bolli, P, Chockalingam, A, Cutler, H, Taylor, G, Hamet, P
Publicado em 1999

Plasma lipid fractions during long-term monotherapy with the ISA-containing beta-adrenoceptor blocker bopindolol in hypertensive patients.

Por Van Brummelen, P, Bolli, P, Koolen, M I, Staehelin, H B, Bühler, F R
Publicado em 1984

Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily

Por Müller, F. B., Allsopp, L. F., Cooper, G. L., Bolli, P., Frei, P., Glaus, L., Ritz, R., Bühler, F. R.
Publicado em 1985

1999 Canadian recommendations for the management of hypertension

Por Feldman, R D, Campbell, N, Larochelle, P, Bolli, P, Burgess, E D, Carruthers, S G, Floras, J S, Haynes, R B, Honos, G, Leenen, F H, Leiter, L A, Logan, A G, Myers, M G, Spence, J D, Zarnke, K B
Publicado em 1999